Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray

One of the most promising trials currently open.
Post Reply
D.ap
Senior Member
Posts: 4137
Joined: Fri Jan 18, 2013 11:19 am

Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray

Post by D.ap »

Abstract
The aim of the present study was to identify the target genes of cediranib and the associated signaling pathways in alveolar soft part sarcoma (ASPS). A microarray dataset (GSE32569) was obtained from the Gene Expression Omnibus database. The R software package was used for data normalization and screening of differentially expressed genes (DEGs). The Database for Annotation, Visualization and Integrated Discovery was used to perform Gene Ontology analysis. Gene Set Enrichment Analysis was performed to obtain the up‑ and downregulated pathways in ASPS. The Distant Regulatory Elements of co‑regulated genes database was used to identify the transcription factors (TFs) that were enriched in the signaling pathways. A protein‑protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins database and was visualized using Cytoscape software. A total of 71 DEGs, including 59 upregulated genes and 12 downregulated genes, were identified. Gene sets associated with ASPS were enriched primarily in four signaling pathways: The phenylalanine metabolism pathway, the mitogen‑activated protein kinase (MAPK) signaling pathway, the taste transduction pathway and the intestinal immune network for the production of immunoglobulin A. Furthermore, 107 TFs were identified to be enriched in the MAPK signaling pathway. Certain genes, including those coding for Fms-like tyrosine kinase 1, kinase insert domain receptor, E‑selectin and platelet‑derived growth factor receptor D, that were associated with other genes in the PPI network, were identified. The present study identified certain potential target genes and the associated signaling pathways of cediranib action in ASPS, which may be helpful in understanding the efficacy of cediranib and the development of new targets for cediranib.



https://www.spandidos-publications.com/ ... 3/download
Debbie
D.ap
Senior Member
Posts: 4137
Joined: Fri Jan 18, 2013 11:19 am

Re: Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray

Post by D.ap »

* the sequence of events involved in converting the detection of chemical molecules into taste signals. Gustatory stimuli interact with the microvillus of a taste cell, which results in changes in activity in the ion channels within taste receptors.
Debbie
D.ap
Senior Member
Posts: 4137
Joined: Fri Jan 18, 2013 11:19 am

Re: Identification of target genes of cediranib in alveolar soft part sarcoma using a gene microarray

Post by D.ap »

D.ap wrote: Tue Apr 10, 2018 6:23 pm Abstract
The aim of the present study was to identify the target genes of cediranib and the associated signaling pathways in alveolar soft part sarcoma (ASPS). A microarray dataset (GSE32569) was obtained from the Gene Expression Omnibus database. The R software package was used for data normalization and screening of differentially expressed genes (DEGs). The Database for Annotation, Visualization and Integrated Discovery was used to perform Gene Ontology analysis. Gene Set Enrichment Analysis was performed to obtain the up‑ and downregulated pathways in ASPS. The Distant Regulatory Elements of co‑regulated genes database was used to identify the transcription factors (TFs) that were enriched in the signaling pathways. A protein‑protein interaction (PPI) network was constructed using the Search Tool for the Retrieval of Interacting Genes/Proteins database and was visualized using Cytoscape software. A total of 71 DEGs, including 59 upregulated genes and 12 downregulated genes, were identified. Gene sets associated with ASPS were enriched primarily in four signaling pathways: The phenylalanine metabolism pathway, the mitogen‑activated protein kinase (MAPK) signaling pathway, the taste transduction pathway and the intestinal immune network for the production of immunoglobulin A. Furthermore, 107 TFs were identified to be enriched in the MAPK signaling pathway. Certain genes, including those coding for Fms-like tyrosine kinase 1, kinase insert domain receptor, E‑selectin and platelet‑derived growth factor receptor D, that were associated with other genes in the PPI network, were identified. The present study identified certain potential target genes and the associated signaling pathways of cediranib action in ASPS, which may be helpful in understanding the efficacy of cediranib and the development of new targets for cediranib.



https://www.spandidos-publications.com/ ... 3/download


* the sequence of events involved in converting the detection of chemical molecules into taste signals. Gustatory stimuli interact with the microvillus of a taste cell, which results in changes in activity in the ion channels within taste receptors.
Debbie
Post Reply

Return to “Cediranib”